Triton WR-1339

Known as: WR-1339, triton WR 1339 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Phospholipids carried by very low density lipoprotein (VLDL) are hydrolysed in circulation by lipoprotein and hepatic lipases and… (More)
Is this relevant?
1988
1988
To test directly the possibility that substances in extracellular fluid can gain access to renin storage granules in renal… (More)
Is this relevant?
1981
1981
After administration (1 g/kg every other day for a total of five injections) of Triton WR-1339, the tonic, anterior (ALD) and… (More)
Is this relevant?
1981
1981
The characteristics of lipoprotein lipolytic activity in lysosomes after the administration of Triton WR-1339 were studied, and… (More)
Is this relevant?
1980
1980
The mode of inhibition of Triton WR 1339 (oxyethylated t-octylphenol polymethylene polymer) on postheparin lipolytic activity and… (More)
Is this relevant?
1979
1979
Changes in whole plasma and lipoprotien apoprotein concentrations were determined after a single injection of Triton WR 1339 into… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
1978
1978
Triton WR 1339, injected intravenously into rats, caused a 12% decrease in hepatic cholesterol within 30 minutes and a 34… (More)
Is this relevant?
1976
1976
1. Lipoprotein lipase activity was measured in heart homogenates and in heparin-releasable and non-releasable fractions of… (More)
  • table 2
  • figure 1
  • table 3
Is this relevant?
1967
1967
1. The initial rate of removal from the circulation of injected [(14)C] labelled chylomicron triglyceride is much slower in rats… (More)
Is this relevant?
1952
1952
Injection of triton WR-1339 into rats leads to a rapid increase in the cholesterol, cholate, and various lipid fractions of their… (More)
  • table I
  • table II
  • table V
Is this relevant?